DAILY UPDATE
Oct 5, 2017
Greetings!

Jason Stutman's latest ad about a microcap stock has gotten the attention of quite a few Gumshoe readers -- he's pitching a medical miracle, a "simple burst of lifesaving medication" that can, as you'd guess from that Lazarus reference, bring the dead back to life.  So what's the actual story, and is there something real behind the dreams of 29,000% sales growth that the ad uses to tantalize us?  Just click below to...

Incredible new cancer screener has a 97% accuracy rate, and more than 80 million stand to benefit! With a value well over $4 billion, this company is no penny stock - and those investors that get in NOW could profit for years to come! All you need is your name and an active email address to get this exclusive FREE report delivered directly to your inbox. Don't miss out on what could be a life-changing investment!
BONUS: After you receive your Free Report, you will have the opportunity to try GorillaTrades' risk-averse trading system absolutely FREE for the next 30 days! All you need is your name and an active email address to gain instant access to expert stock picks, options picks, newsletters, and more! 
There is NO CREDIT CARD REQUIRED!
Advertisement
Gerardo Del Real has been teasing his "Gold-X" idea for buying appealing mining stocks for a while now, so after getting a few more questions about it I decided to throw the Thinkolator at this puzzle -- what's this special kind of mining stock he thinks you should buy, and which three of them top his list for potential upside of 2,300%, 800%, and 1,100%?  Just click below to...
Dr. KSS is also live-blogging another conference today -- he's at the MicroCap Conference in New York to see what he can learn about some more small biotech stocks, the Irregulars can follow along by clicking here.

IRREGULARS CORNER

Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
Stock Gumshoe, 351 Pleasant St., Suite B #205, Northampton, MA 01060
Sent by travis@stockgumshoe.com in collaboration with
Constant Contact